Markets:

Overview

News

Currencies

International

Treasuries

Maze Therapeutics, Inc. - Common Stock (NQ:MAZE)

42.44 +0.14 (+0.33%)

Streaming Delayed Price Updated: 10:38 AM EST, Dec 24, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Maze Therapeutics, Inc. - Common Stock

Foresite Capital Goes Bullish on Cytokinetics (CYTK), Snapping Up 458K Shares ↗

December 08, 2025

Foresite Capital Goes Bullish on Cytokinetics (CYTK), Snapping Up 458K Shares

Via The Motley Fool

Topics Regulatory Compliance

Biotech Breakouts: 3 Stocks With Massive Upside Potential ↗

September 17, 2025

Biotech stocks are highly volatile; however, these biotech stocks have key trial results this fall that could spark sharp moves and long-term growth potential

Via MarketBeat

What's going on in today's session ↗

September 11, 2025

Curious to know what's happening on the US markets one hour before the close of the markets on Thursday? Join us as we explore the top gainers and losers in today's session.

Via Chartmill

Maze Shares Jump As Investors Bet Big On Experimental Treatment's Potential ↗

September 11, 2025

Maze's MZE782 showed strong Phase 1 results, supporting once- or twice-daily dosing with increased amino acid excretion and no serious side effects.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

September 11, 2025

Via Benzinga

Which stocks are moving on Thursday? ↗

September 11, 2025

Looking for insights into the US markets in the middle of the day on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Via Chartmill

Maze Therapeutics, Opendoor Technologies, Oxford Industries, VNET Group And Other Big Stocks Moving Higher On Thursday ↗

September 11, 2025

Via Benzinga

Thursday's session: gap up and gap down stocks ↗

September 11, 2025

Let's have a look at the gap up and gap down stocks in today's session.

Via Chartmill

Why Maze Therapeutics, Up 51%, Was Shocked By Its Own Test Results ↗

September 11, 2025

Shares catapulted Thursday after its experimental treatment for a rare, genetic disease blew past expectations.

Via Investor's Business Daily

Discover the top movers in Thursday's pre-market session. ↗

September 11, 2025

As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

September 11, 2025

Via Benzinga

Maze Therapeutics Inc (NASDAQ:MAZE) Reports Narrower Q2 2025 Loss, Extends Cash Runway to 2027 ↗

August 12, 2025

Maze Therapeutics reports Q2 2025 earnings with a narrower loss than expected, extends cash runway to 2027, and advances kidney disease clinical trials.

Via Chartmill

12 Health Care Stocks Moving In Monday's After-Market Session ↗

July 28, 2025

Via Benzinga

This Celsius Holdings Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday ↗

July 23, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

July 16, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

May 28, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

April 25, 2025

Via Benzinga

Booz Allen Hamilton, Movado Group And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

April 11, 2025

Via Benzinga

Why Argenx Shares Are Trading Higher By 5%; Here Are 20 Stocks Moving Premarket ↗

April 11, 2025

Via Benzinga

Greenbrier, RPM International, CVRx And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

April 08, 2025

Via Benzinga

Why Chanson International Holding Shares Are Trading Higher By Around 170%; Here Are 20 Stocks Moving Premarket ↗

April 07, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

April 04, 2025

Via Benzinga

JOYY, Akebia Therapeutics, Microchip Technology And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

March 20, 2025

Via Benzinga

Why Five Below Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket ↗

March 20, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

March 17, 2025

Via Benzinga

This Insmed Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday ↗

February 25, 2025

Via Benzinga

Tesla, ON Semiconductor And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

February 10, 2025

Via Benzinga

Why BP Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket ↗

February 10, 2025

Via Benzinga

Infinity Natural Resources Valued At $1.3 Billion In Market Debut ↗

February 02, 2025

Shares of Infinity Natural Resources jumped almost 11% in their NYSE debut, valuing the oil and natural gas producer at $1.3 billion. The listing arrived amid a more fossil fuel-friendly White House...

Via Talk Markets

Topics Energy Stocks / Equities

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Maze Therapeutics, Inc. - Common Stock (NQ:MAZE)

Headline News about Maze Therapeutics, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today